Current status: 895 hESC lines, 3950 hiPSC lines, and 117 clinical studies, and 809 certificates
Monthly statistic from Jun 1, 2023
Posted on June 1, 2023
| total lines | 4845 |
| hESC lines | 895 |
| hiPSC lines | 3950 |
| derivation countries | 46 |
| projects | 272 |
| providers | 814 |
| clinical studies | 117 |
| subclones | 2134 |
| certificates | 809 |
| cell line certificates | 672 |
| project certificates | 137 |